✦ LIBER ✦

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes

✍ Scribed by Aschner, P.; Kipnes, M. S.; Lunceford, J. K.; Sanchez, M.; Mickel, C.; Williams-Herman, D. E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Efficacy and tolerability of the dipepti

✍ R. Scott; M. Wu; M. Sanchez; P. Stein 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INH

✍ Sara Stafford; Dariush Elahi; Graydon S. Meneilly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

A dipeptidyl peptidase-4 inhibitor, sita

✍ Satoh-Asahara, Noriko; Sasaki, Yousuke; Wada, Hiromichi; Tochiya, Mayu; Iguchi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 191 KB

The dipeptidyl peptidase-4 inhibitor alo

✍ Fujii, Yuki; Abe, Masanori; Higuchi, Terumi; Mizuno, Mari; Suzuki, Hiroko; Matsu 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 379 KB

Dipeptidyl Peptidase-4 Inhibitors for th

✍ Herman, G A; Stein, P P; Thornberry, N A; Wagner, J A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 160 KB